# Oxytocin Antagonist in Patients With Repeated Failure of Implantation

> **NCT01673399** · PHASE4 · COMPLETED · sponsor: **AZ Jan Palfijn Gent** · enrollment: 138 (actual)

## Conditions studied

- Implantation Failure

## Interventions

- **DRUG:** Atosiban
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01673399
- **Lead sponsor:** AZ Jan Palfijn Gent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2021-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673399, "Oxytocin Antagonist in Patients With Repeated Failure of Implantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01673399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*